This is a Validated Antibody Database (VAD) review about rhesus mac.. LAMP1, based on 14 published articles (read how Labome selects the articles), using LAMP1 antibody in all methods. It is aimed to help Labome visitors find the most suited LAMP1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (H4A3)
  • flow cytometry; human; 1:200; loading ...; fig 5d
BioLegend LAMP1 antibody (Biolegend, 328606) was used in flow cytometry on human samples at 1:200 (fig 5d). elife (2020) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; loading ...; fig 3f
BioLegend LAMP1 antibody (Biolegend, 328620) was used in flow cytometry on human samples (fig 3f). elife (2019) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; loading ...; fig 4c
BioLegend LAMP1 antibody (BioLegend, 328624) was used in flow cytometry on human samples (fig 4c). J Clin Invest (2018) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; loading ...; fig 4a
BioLegend LAMP1 antibody (Biolegend, 328640) was used in flow cytometry on human samples (fig 4a). Cell (2018) ncbi
mouse monoclonal (H4A3)
  • immunocytochemistry; pigs ; fig 3e
BioLegend LAMP1 antibody (BioLegend, 328602) was used in immunocytochemistry on pigs samples (fig 3e). Biochim Biophys Acta Mol Cell Biol Lipids (2017) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; loading ...; fig 6a
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend LAMP1 antibody (Biolegend, H4A3) was used in flow cytometry on human samples (fig 6a). PLoS Pathog (2016) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend LAMP1 antibody (Biolegend, H4A3) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human
BioLegend LAMP1 antibody (Biolegend, Clone H4A3) was used in flow cytometry on human samples . Int J Infect Dis (2015) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human
BioLegend LAMP1 antibody (Biolegend, Clone H4A3) was used in flow cytometry on human samples . Int J Infect Dis (2015) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; fig 4
BioLegend LAMP1 antibody (Biolegend, H4A3) was used in flow cytometry on human samples (fig 4). J Immunol (2015) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; fig 4
BioLegend LAMP1 antibody (BioLegend, H4A3) was used in flow cytometry on human samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (H4A3)
  • immunocytochemistry; mouse; 1:100; fig 5
In order to characterize the PmpG-1-vault vaccine-induced immune response, BioLegend LAMP1 antibody (Biolegend, H4A3) was used in immunocytochemistry on mouse samples at 1:100 (fig 5). Vaccine (2015) ncbi
mouse monoclonal (H4A3)
  • flow cytometry; human; loading ...; fig 3d
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend LAMP1 antibody (BioLegend, H4A3) was used in flow cytometry on human samples (fig 3d). Blood (2014) ncbi
mouse monoclonal (H4A3)
BioLegend LAMP1 antibody (BioLegend, H4A3) was used . J Leukoc Biol (2014) ncbi
Articles Reviewed
  1. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  2. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed publisher
  3. Kuranda K, Jean Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018;128:5267-5279 pubmed publisher
  4. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  5. Kober A, Manavalan A, Tam Amersdorfer C, Holmér A, Saeed A, Fanaee Danesh E, et al. Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:573-588 pubmed publisher
  6. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  7. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  8. Axelsson Robertson R, Rao M, Loxton A, Walzl G, Bates M, Zumla A, et al. Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Int J Infect Dis. 2015;32:23-9 pubmed publisher
  9. Axelsson Robertson R, Ju J, Kim H, Zumla A, Maeurer M. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis. Int J Infect Dis. 2015;32:13-22 pubmed publisher
  10. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  11. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  12. Zhu Y, Jiang J, Saïd Sadier N, Boxx G, Champion C, Tetlow A, et al. Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope. Vaccine. 2015;33:298-306 pubmed publisher
  13. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  14. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher